Registration for a live webinar on 'The role of T cells in COVID from asymptomatic to severe outcomes' is now open.
See webinar details
Dr. Bernd Mayer emergentec biodevelopment GmbH, Vienna, Austria
1 TalkBiography
Bernd Mayer is Managing Partner at emergentec and Associate at the Institute of Theoretical Chemistry, University of Vienna. He received his University training in Molecular Biology at the University of Vienna, and after several PostDoc positions in Vienna, Italy and USA co-founded emergentec. Bernd’s area of interest is applied Computational... read moreBiology with specific focus on biomarkers and targets for use in human disease.
